| Thu, Jul 9, 2009 | | | Rigel says rheumatoid arthritis drug met goal AP (Thu 6:45pm)
| | | RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online (Thu 5:19pm)
| | | Retail Blues Can't Sink Market Indie Research (Thu 5:00pm)
| | | Yes! It Can Handle the Pressure at Motley Fool (Thu 3:55pm)
| | | Rigel's R788 Drug Improves RA Symptoms at TheStreet.com (Thu 10:31am)
| | | Rigel Pharmaceuticals, MSC Software and Blue Nile lead small-cap volume in pre-market SmallCapInvestor.com (Thu 9:21am)
| | | UPDATE - Rigel's says arthritis drug shows progress at Reuters (Thu 8:35am)
| | | Rigel R788 in RA Phase 2b Taski2 Results Call scheduled for 8:00 am ET today CCBN (Thu 8:00am)
| | | Rigel reports positive results from R788 study at MarketWatch (Thu 6:11am)
| | | Rigel's R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial PR Newswire (Thu 6:00am)
| | Wed, Jul 8, 2009 | | | Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi2 Clinical Trial of R788 in Rheumatoid Arthritis PR Newswire (Wed, Jul 8)
| | Fri, Jun 26, 2009 | | | The $16 Billion Market That Could Make You Rich at Motley Fool (Fri, Jun 26)
| | Tue, Jun 16, 2009 | | | Coverage initiated on Rigel Pharms by Boenning & Scattergood Briefing.com (Tue, Jun 16)
| | Mon, Jun 15, 2009 | | | New RA Data Could Be Magic Pill for Rigel at TheStreet.com (Mon, Jun 15)
| | Wed, Jun 10, 2009 | | | Biotech Calendar: Key Clinical Trial Dates at TheStreet.com (Wed, Jun 10)
| | | Rigel to Present at Jefferies Healthcare Conference PR Newswire (Wed, Jun 10)
| | Tue, Jun 9, 2009 | | | Movers roundup: Rigel Pharma, Mueller Water AP (Tue, Jun 9)
| | | Analyst: Rigel arthritis drug poised to compete AP (Tue, Jun 9)
| | Mon, Jun 1, 2009 | | | Rigel's R788 Evaluated in Phase 2 Trial in Multiple Cancers PR Newswire (Mon, Jun 1)
| | Wed, May 13, 2009 | | | Rigel to Present at JMP Securities Research Conference PR Newswire (Wed, May 13)
| Add RIGL News to My Yahoo!:

| |
|